These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33157224)

  • 1. Valproic acid alters nitric oxide status in neurulating mouse embryos.
    Tiboni GM; Ponzano A; Ferrone A; Franceschelli S; Speranza L; Patruno A
    Reprod Toxicol; 2021 Jan; 99():152-159. PubMed ID: 33157224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the effects of in utero valproic acid exposure on NF-κB signaling in CD-1 mouse embryos during neural tube closure.
    Shafique S; Winn LM
    Neurotoxicol Teratol; 2021; 83():106941. PubMed ID: 33212164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
    Dawson JE; Raymond AM; Winn LM
    Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nitric oxide synthesis enhances teratogenic effects induced by valproic Acid.
    Tiboni GM; Chiarelli F; Verrotti A
    In Vivo; 2013; 27(4):513-8. PubMed ID: 23812222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects.
    Akimova D; Wlodarczyk BJ; Lin Y; Ross ME; Finnell RH; Chen Q; Gross SS
    Birth Defects Res; 2017 Jan; 109(2):106-119. PubMed ID: 27860192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal evaluation of the mouse embryonic redox environment and histiotrophic nutrition following treatment with valproic acid and 1,2-dithiole-3-thione during early organogenesis.
    Lapehn S; Piorczynski TB; Hansen JM; Harris C
    Reprod Toxicol; 2021 Apr; 101():81-92. PubMed ID: 33713778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of nuclear factor-κB signaling and reduction of neural tube defects by quercetin-3-glucoside in embryos of diabetic mice.
    Tan C; Meng F; Reece EA; Zhao Z
    Am J Obstet Gynecol; 2018 Aug; 219(2):197.e1-197.e8. PubMed ID: 29733843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture.
    Bruckner A; Lee YJ; O'Shea KS; Henneberry RC
    Teratology; 1983 Feb; 27(1):29-42. PubMed ID: 6405496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational exposure to valproic acid upregulates total Stat3 protein expression while downregulating phosphorylated Stat3 in CD-1 mouse embryos with neural tube defects.
    Shafique S; Winn LM
    Birth Defects Res; 2020 Apr; 112(7):555-568. PubMed ID: 32134217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Cbp, p300 and Akt in valproic acid induced neural tube defects in CD-1 mouse embryos.
    Shafique S; Winn LM
    Reprod Toxicol; 2020 Aug; 95():86-94. PubMed ID: 32445665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid.
    Radatz M; Ehlers K; Yagen B; Bialer M; Nau H
    Epilepsy Res; 1998 Mar; 30(1):41-8. PubMed ID: 9551843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycomb homologs are involved in teratogenicity of valproic acid in mice.
    Okada A; Aoki Y; Kushima K; Kurihara H; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):870-9. PubMed ID: 15523661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an in vitro teratology system using chiral substances: stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos.
    Andrews JE; Ebron-McCoy M; Bojic U; Nau H; Kavlock RJ
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):310-6. PubMed ID: 7785058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid-induced alterations in growth and neurotrophic factor gene expression in murine embryos [corrected].
    Bennett GD; Wlodarczyk B; Calvin JA; Craig JC; Finnell RH
    Reprod Toxicol; 2000; 14(1):1-11. PubMed ID: 10689198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific effects of valproic acid on DNA repair genes and apoptosis in postimplantation mouse embryos.
    Lamparter C; Winn LM
    Toxicol Sci; 2014 Sep; 141(1):59-67. PubMed ID: 24913804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U; Volland J; Nau H
    Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V; Wlodarczyk B; Giavini E; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A; Göttlicher M; Nau H
    ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronotoxicity of sodium valproate in pregnant mouse and embryo.
    Ohdo S; Watanabe H; Ogawa N; Yoshiyama Y; Sugiyama T
    Jpn J Pharmacol; 1996 Mar; 70(3):253-8. PubMed ID: 8935719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.